Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Submission Of Compliance Certificate Under Regulation 7(3) Of SEBI (LODR) Regulations, 2015 For The Year Ended 31St March, 2023

 With reference to the above subject, please find enclosed Compliance Certificate for the year ended 31st March, 2023 duly signed by the Company Secretary & Compliance Officer and authorized representative of the Share Transfer Agent i.e. KFin Technologies Limited, Hyderabad, under Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
11-04-2023
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 This is to inform that the details of securities dematerialized/ rematerialized during the quarter ended March 31, 2023, as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, have been furnished by KFin Technologies Limited, Registrar & Transfer Agent (RTA) of the Company to the stock exchanges where the shares of the Company are listed. Letters confirming this from KFin Technologies Limited dated April 06, 2023 are enclosed for your reference.
11-04-2023
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Closure of Trading Window

 We wish to inform that the "Trading Window" for dealing in the securities of the Company will be closed for the Designated Persons, their immediate relatives covered under the said Code of the Company from 1st April, 2023 and the same will remain closed till 48 hours after the declaration of Financial Results for the quarter and year ending 31st March, 2023, to the public, in terms of the Code of Conduct of the Company under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
29-03-2023
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in terms of SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated January 25, 2022, this is to inform you that the Company has received intimation from our RTA dated March 09, 2023 regarding issue of 'Letter of Confirmation' in lieu of share certificate(s) reported as lost/misplaced details are as per the letter attached below.
09-03-2023
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - SBO Change - Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations').

 This is to inform you that the Board of Directors of the Company have been informed by our Promoter Group entity - Jasti Property and Equity Holdings Private Limited (in its capacity as sole trustee of Jasti Family Trust), that the Significant Beneficial Owner (SBO) Mr Subba Rao Jasti, father of Shri Venkateswarlu Jasti, CEO of our company has passed away on 2nd February 2023. In terms of the WILL executed by Mr Subba Rao Jasti, the 9,980 equity shares held by him in the said promoter group entity devolved and transmitted to Mrs. Sudharani Jasti on 08th March, 2023, one of the promoter of our company. Post this transmission Mrs. Sudharani Jasti becomes SBO of the listed entity.
08-03-2023
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform that the Company has received intimation from the RTA (Registrar & Share Transfer Agent) i.e. Kfin Technologies Limited regarding loss of share certificate(s), details are as per letter attached below.
06-03-2023
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

 Pursuant to Regulation 82(4) of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirement) Regulations, 2018 and Regulation 32 (6) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Monitoring Agency Report with respect to utilization of proceeds of the Rights Issue of the Company for the quarter ended on December 31, 2022, issued by CRISIL Ratings Limited, Monitoring Agency.
09-02-2023
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed the copies of the newspaper advertisement regarding Un-audited Financial Results of the Company for quarter ended 31st December, 2022. The advertisements are as appeared on 03rd February, 2023 in Business Standard and Andhra Prabha (Telugu).
03-02-2023

Suven Life Sci Standalone December 2022 Net Sales at Rs 3.00 crore, down 32.27% Y-o-Y

 NULL
02-02-2023
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Statement Of Deviation(S) Or Variation(S) For Quarter Ended 31St December, 2022 Under Regulation 32 Of SEBI (LODR) Regulations, 2015

 With reference to the above subject, please find enclosed statement confirming that there were no deviation(s) or variation(s) in the use of proceeds, from the objects for which funds were raised through the preferential issue made by the Company, for the quarter ended 31st December, 2022.
02-02-2023
Next Page
Close

Let's Open Free Demat Account